Prevalensi Terjadinya Komplikasi pada Ibu Hamil dengan Infeksi Covid-19 Post Sectio Caesarea
DOI:
https://doi.org/10.46815/jk.v13i1.187Kata Kunci:
COVID-19, Ibu Hamil, Komplikasi, Sectio CaesareaAbstrak
Kehamilan merupakan periode pertumbuhan dan perkembangan janin disertai dengan perubahan fisiologis dan imunologis ibu sehingga lebih rentan mengalami infeksi, termasuk infeksi COVID-19. Kehamilan yang disertai dengan infeksi COVID-19 meningkatkan risiko terjadinya komplikasi terhadap ibu hamil. Penelitian ini bertujuan untuk mengetahui prevalensi terjadinya komplikasi post Section Caesarea pada ibu hamil dengan infeksi COVID-19. Metode pengambilan sampel menggunakan purposive sampling dengan melakukan pengamatan data rekam medis di RSPAL dr. Ramelan Surabaya periode Maret 2020 – Maret 2023. Dari total 100 sampel, terdapat 58 kasus yang terkonfirmasi COVID-19 dengan 8 kasus (32,0%) komplikasi kardiovaskular berupa 6 kasus (75,0%) komplikasi PPH dan 2 kasus (25,0%) komplikasi infeksi luka operasi. Prevalensi komplikasi pada saluran pernapasan didapatkan 13 kasus (52,0%) berupa 9 kasus (69,2%) komplikasi pneumonia dan 4 kasus (30,8%) komplikasi ARDS. Komplikasi sepsis didapatkan 1 kasus (4,0%) dan 3 kasus (12,0%) komplikasi kematian pada ibu. Hasil analisis data mengunakan uji Koefisien Kontingensi menunjukkan nilai p-value = 0,001 (p < α). Terdapat hubungan antara infeksi COVID-19 dengan peningkatan prevalensi terjadinya komplikasi pada ibu hamil dan post Sectio Caesarea. Sehingga dalam penelitian ini didapatkan 25 kasus (43,1%) komplikasi post Sectio Caesarea pada ibu hamil dengan infeksi COVID-19 dan terdapat peningkatan prevalensi terjadinya komplikasi pada ibu hamil dengan infeksi COVID-19 post Sectio Caesarea.
Unduhan
Referensi
Archie, A. M., Ristyaning, P., Sangging, A., Ismunandar, H., & Tjiptaningrum, A. (2022). Gangguan Hemostasis dengan Covid-19. Medical Proffesion Journal of Lampung, Vol. 12, 14–25.
Benhamou, D., Keita, H., & Ducloy-Bouthors, A. S. (2020, June 1). Coagulation changes and thromboembolic risk in COVID-19 obstetric patients. Anaesthesia Critical Care and Pain Medicine, Vol. 39, pp. 351–353. Elsevier Masson SAS. https://doi.org/10.1016/j.accpm.2020.05.003
Boelig, R. C., Saccone, G., Bellussi, F., & Berghella, V. (2020). MFM guidance for COVID-19. American Journal of Obstetrics & Gynecologic MFM, 2 (20). https://doi.org/10.1016/j.ajogmf.2020.100106
D’Souza, R., Ashraf, R., Rowe, H., Zipursky, J., Clarfield, L., Maxwell, C., … Malhamé, I. (2021). Pregnancy and COVID-19: pharmacologic considerations. Ultrasound in Obstetrics and Gynecology, 57(2), 195–203. https://doi.org/10.1002/UOG.23116
Ferrer-Oliveras, R., Mendoza, · Manel, Sira Capote, ·, Laia Pratcorona, ·, Esteve-Valverde, E., Cabero-Roura, L., & Alijotas-Reig, J. (2021). Immunological and physiopathological approach of COVID-19 in pregnancy. Archives of Gynecology and Obstetrics, 304, 39–57. https://doi.org/10.1007/s00404-021-06061-3
Hantoushzadeh, S., Shamshirsaz, A. A., Aleyasin, ; Ashraf, Seferovic, M. D., Soudabeh, ;, Aski, K., … Aagaard, K. (2020). Maternal death due to COVID-19. American Journal of Obstetrics & Gynecology. https://doi.org/10.1016/j.ajog.2020.04.030
Januszewski, M., Santor-Zaczyńska, M., Ziuzia-Januszewska, L., Kudan, M., Jakimiuk, A. A., Wierzba, W., & Jakimiuk, A. J. (2022). Postpartum Blood Loss in COVID-19 Patients—Propensity Score Matched Analysis. Biomedicines, 10(10). https://doi.org/10.3390/biomedicines10102517
Koçak Tufan, Z., Kayaaslan, B., & Mer, M. (2021). COVID-19 and Sepsis. Turkish Journal of Medical Sciences, 51(1), 18. https://doi.org/10.3906/sag-2108-239
Le, M. K., & Nguyen, T. H. (2022). Peripartum Cardiomyopathy-Induced Cardiogenic Shock Causing Hypoxic-Ischemic Encephalopathy in a COVID-19 Patient. Case Reports in Critical Care, 2022. https://doi.org/10.1155/2022/7114732
Lim, M. J., Lakshminrusimha, S., Hedriana, H., & Albertson, T. (2023). Pregnancy and Severe ARDS with COVID-19: Epidemiology, Diagnosis, Outcomes and Treatment. Seminars in Fetal and Neonatal Medicine, 28. https://doi.org/10.1016/j.siny.2023.101426
Marfu’ah, U., Rofi’ah, S., & Musyafak, N. (2022, February 21). Women’s Vulnerability in Performing Reproductive Functions in the Covid-19 Pandemic. European Alliance for Innovation n.o. https://doi.org/10.4108/eai.15-9-2021.2315802
Qeadan, F., Mensah, N. A., Tingey, B., & Stanford, J. B. (2021). The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis. 21. https://doi.org/10.1186/s12884-021-03772-y
Rasmussen, S. A., Smulian, J. C., Lednicky, J. A., Wen, T. S., & Jamieson, D. J. (2020, May 1). Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. American Journal of Obstetrics and Gynecology, Vol. 222, pp. 415–426. Mosby Inc. https://doi.org/10.1016/j.ajog.2020.02.017
Schwartz, D. A., & Graham, A. L. (2020). viruses Perspective Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. https://doi.org/10.3390/v12020194
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2024 Nadila Rizqi Utami, Mita Herdiyantini, Retno Budiarti, Titut Harnanik
Artikel ini berlisensi Creative Commons Attribution 4.0 International License.
